2018 annual financial data
X4 Pharmaceuticals 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -726.29%.
Operating income was -29,085,000 USD and net income was -33,284,999 USD.
Operating cash flow was -25,420,000 USD.
Get free X4 Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,500,000 USD
- Operating income
- -29,085,000 USD
- Net income
- -33,284,999 USD
- Operating cash flow
- -25,420,000 USD